| Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer (NCT04044430) | University of California, San Francisco | 2020-08-31 |
| Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites (NCT04267575) | Jerome Canady, M.D. | 2019-07-30 |
| Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (NCT04046445) | Amal Therapeutics | 2019-07-22 |
| Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer (NCT04113096) | The University of The West Indies | 2018-10-01 |
| Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases (NCT03717519) | Azienda Ospedaliera Universitaria Integrata Verona | 2018-01-01 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| A Retrospective Cohort Study Outcome of Treatment in Asymptomatic Stage 4 Colorectal Cancer (NCT04334395) | Mahidol University | 2017-01-01 |
| Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy (NCT01934179) | Fox Chase Cancer Center | 2013-10-01 |
| Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab (NCT01814501) | John Hays | 2013-02-01 |
| Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer (NCT01652196) | John Hays | 2012-11-14 |
| Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer (NCT01191684) | City of Hope Medical Center | 2011-10-01 |
| Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (NCT01205022) | City of Hope Medical Center | 2011-04-01 |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer (NCT01294826) | Swedish Medical Center | 2011-02-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer (NCT01285102) | Fox Chase Cancer Center | 2010-10-01 |
| Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy (NCT01238965) | University of Southern California | 2010-10-01 |
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274) | National Cancer Institute (NCI) | 2010-06-01 |
| RO4929097 in Treating Patients With Metastatic Colorectal Cancer (NCT01116687) | National Cancer Institute (NCI) | 2010-05-01 |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (NCT01126346) | Wake Forest University Health Sciences | 2010-05-01 |
| Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer (NCT01105377) | National Cancer Institute (NCI) | 2010-04-01 |
| Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery (NCT00835679) | National Cancer Institute (NCI) | 2009-12-01 |
| Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer (NCT01037790) | Abramson Cancer Center at Penn Medicine | 2009-10-01 |
| Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (NCT00826540) | Alliance for Clinical Trials in Oncology | 2009-09-01 |
| Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment (NCT00942266) | Roswell Park Cancer Institute | 2009-07-01 |
| Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Cancer Patients (NCT01483443) | Gachon University Gil Medical Center | 2008-08-01 |
| Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer (NCT00551421) | National Cancer Institute (NCI) | 2007-10-01 |
| Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer (NCT00504153) | National Cancer Institute (NCI) | 2007-07-01 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer (NCT00397878) | National Cancer Institute (NCI) | 2006-11-01 |
| VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer (NCT00407654) | National Cancer Institute (NCI) | 2006-10-01 |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors (NCT00138177) | National Cancer Institute (NCI) | 2005-07-01 |
| Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00134069) | National Cancer Institute (NCI) | 2005-06-01 |
| Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery (NCT00645710) | City of Hope Medical Center | 2005-02-11 |
| Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348) | National Cancer Institute (NCI) | 2005-01-01 |
| Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer (NCT00100841) | National Cancer Institute (NCI) | 2004-11-01 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191) | National Cancer Institute (NCI) | 2004-05-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer (NCT00070122) | National Cancer Institute (NCI) | 2004-04-01 |
| Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer (NCT00052585) | National Cancer Institute (NCI) | 2002-10-01 |
| Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer (NCT00041340) | National Cancer Institute (NCI) | 2002-05-01 |
| Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver (NCT00026234) | National Cancer Institute (NCI) | 2002-02-01 |
| Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00032110) | National Cancer Institute (NCI) | 2002-01-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496) | National Cancer Institute (NCI) | 2001-11-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer (NCT00023933) | National Cancer Institute (NCI) | 2001-10-01 |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated (NCT00025337) | National Cancer Institute (NCI) | 2001-09-01 |
| SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer (NCT00005818) | National Cancer Institute (NCI) | 2000-03-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer (NCT00003873) | National Cancer Institute (NCI) | 1999-04-01 |
| Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver (NCT00019760) | National Institutes of Health Clinical Center (CC) | 1999-04-01 |
| Antineoplaston Therapy in Treating Patients With Colon Cancer (NCT00003486) | Burzynski Research Institute | |